InsightfulValue
← Home

Astellas Pharma
Astellas Pharma

Pharma / Pharmaceuticals, Healthcare


πŸ”§ Tools

βœ… Due Diligence
Company at a Glance

Astellas Pharma

πŸ“Š Get full analytics about Astellas Pharma

Sign up for free or log in

πŸš€ Don’t miss "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” free!

Price
Live  
Overview
Astellas Pharma is a Japanese pharmaceutical company that was created in 2005 through the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd. The company focuses on the research, development, and commercialization of pharmaceutical products in a variety of therapeutic areas, including immunology, oncology, and urology.
One of Astellas Pharma's primary areas of focus is in the development of treatments for oncology-related diseases. They have a strong portfolio of oncology products, including treatments for prostate, bladder, and pancreatic cancer. In addition, the company is also committed to developing treatments for rare diseases, such as Duchenne muscular dystrophy and acute myeloid leukemia.
Astellas Pharma also has a global presence, with operations in Asia, Europe, North America, and Latin America. They operate research and development centers in Japan, the United States, and the Netherlands, as well as manufacturing facilities in various countries.
Overall, Astellas Pharma is dedicated to improving the health and well-being of patients worldwide through the development of innovative and effective pharmaceutical products.
What is special about the company?
Astellas Pharma

πŸ“ˆ Want to read more about Astellas Pharma?

Sign up for free or log in

πŸ“˜ Claim your free eBook: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

VGhlcmUgYX JlIGEgZmV3 IHRoaW5ncy B0aGF0IGFy ZSBzcGVjaW FsIGFib3V0 IEFzdGVsbG FzIFBoYXJt YSBhcyBhIG NvbXBhbnk6 PGJyPjEuIF N0cmVuZ3Ro IGluIHJlc2 VhcmNoIGFu ZCBkZXZlbG 9wbWVudDog QXN0ZWxsYX MgUGhhcm1h IGhhcyBhIH N0cm9uZyBm b2N1cyBvbi ByZXNlYXJj aCBhbmQgZG V2ZWxvcG1l bnQsIHdpdG ggYSBzaWdu aWZpY2FudC Bwb3J0aW9u IG9mIGl0cy ByZXZlbnVl cyBiZWluZy BpbnZlc3Rl ZCBpbiB0aG lzIGFyZWEu IFRoaXMgaG FzIGFsbG93 ZWQgdGhlbS B0byBkZXZl bG9wIGlubm 92YXRpdmUg bWVkaWNpbm VzIGFuZCB0 cmVhdG1lbn RzIGZvciBh IHdpZGUgcm FuZ2Ugb2Yg aWxsbmVzc2 VzIGFuZCBj b25kaXRpb2 5zLjxicj4y LiBHbG9iYW wgcHJlc2Vu Y2U6IEFzdG VsbGFzIFBo YXJtYSBpcy BhIHRydWx5 IGdsb2JhbC Bjb21wYW55 LCB3aXRoIG xvY2F0aW9u cyBhbmQgb3 BlcmF0aW9u cyBpbiBvdm VyIDUwIGNv dW50cmllcy B3b3JsZHdp ZGUuIFRoaX MgaGFzIGVu YWJsZWQgdG hlbSB0byBy ZWFjaCBhIG Jyb2FkIG1h cmtldCBhbm QgcHJvdmlk ZSB0aGVpci Bwcm9kdWN0 cyBhbmQgc2 VydmljZXMg dG8gYSBkaX ZlcnNlIHJh bmdlIG9mIH BhdGllbnQg cG9wdWxhdG lvbnMuPGJy PjMuIFBhdG llbnQtY2Vu dHJpYyBhcH Byb2FjaDog QXN0ZWxsYX MgUGhhcm1h IHByaW9yaX RpemVzIHRo ZSBuZWVkcy BhbmQgd2Vs bC1iZWluZy BvZiBwYXRp ZW50cyBhYm 92ZSBhbGwg ZWxzZS4gVG hleSBzdHJp dmUgdG8gdW 5kZXJzdGFu ZCB0aGUgbm VlZHMgb2Yg cGF0aWVudH MgYW5kIHdv cmsgdG8gZG V2ZWxvcCB0 cmVhdG1lbn RzIHRoYXQg YWRkcmVzcy B0aGVpciBz cGVjaWZpYy Bjb25kaXRp b25zLjxicj 40LiBDb21t aXRtZW50IH RvIHN1c3Rh aW5hYmlsaX R5OiBUaGUg Y29tcGFueS BoYXMgYSBz dHJvbmcgY2 9tbWl0bWVu dCB0byBzdX N0YWluYWJp bGl0eSwgaW 1wbGVtZW50 aW5nIGVjby 1mcmllbmRs eSBwcmFjdG ljZXMgYW5k IGluaXRpYX RpdmVzIGlu IGl0cyBvcG VyYXRpb25z IGFuZCBwcm 9kdWN0aW9u IHByb2Nlc3 Nlcy4gVGhl eSBhbHNvIH dvcmsgdG8g ZW5zdXJlIG V0aGljYWwg YW5kIHJlc3 BvbnNpYmxl IGJ1c2luZX NzIHByYWN0 aWNlcy48Yn I+NS4gQ29s bGFib3JhdG l2ZSBwYXJ0 bmVyc2hpcH M6IEFzdGVs bGFzIFBoYX JtYSBiZWxp ZXZlcyBpbi Bjb2xsYWJv cmF0aW9uIG FuZCB3b3Jr aW5nIHdpdG ggb3RoZXIg Y29tcGFuaW VzLCBvcmdh bml6YXRpb2 5zLCBhbmQg aW5kaXZpZH VhbHMgdG8g YWNoaWV2ZS B0aGVpciBt aXNzaW9uIG 9mIGltcHJv dmluZyB0aG UgbGl2ZXMg b2YgcGF0aW VudHMuIFRo ZXkgaGF2ZS Bmb3JtZWQg cGFydG5lcn NoaXBzIHdp dGggdmFyaW 91cyBhY2Fk ZW1pYyBpbn N0aXR1dGlv bnMsIHJlc2 VhcmNoIG9y Z2FuaXphdG lvbnMsIGFu ZCBvdGhlci BwaGFybWEg Y29tcGFuaW VzIHRvIGFk dmFuY2UgaG VhbHRoY2Fy ZSBpbm5vdm F0aW9uLjxi cj42LiBDb3 Jwb3JhdGUg c29jaWFsIH Jlc3BvbnNp YmlsaXR5Oi BBc3RlbGxh cyBQaGFybW EgaXMgY29t bWl0dGVkIH RvIGdpdmlu ZyBiYWNrIH RvIHRoZSBj b21tdW5pdH kgYW5kIGlt cHJvdmluZy BwZW9wbGUn cyBsaXZlcy B0aHJvdWdo IGl0cyBjb3 Jwb3JhdGUg c29jaWFsIH Jlc3BvbnNp YmlsaXR5IG luaXRpYXRp dmVzLiBUaG lzIGluY2x1 ZGVzIGludm VzdGluZyBp biBlZHVjYX Rpb24sIHBy b21vdGluZy BlbXBsb3ll ZSBkaXZlcn NpdHkgYW5k IGluY2x1c2 lvbiwgYW5k IHN1cHBvcn RpbmcgbG9j YWwgY29tbX VuaXRpZXMu
What the company's business model?
Astellas Pharma

πŸ“ˆ Want to read more about Astellas Pharma?

Sign up for free or log in

πŸ“˜ Claim your free eBook: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

QXN0ZWxsYX MgUGhhcm1h IGlzIGEgZ2 xvYmFsIHBo YXJtYWNldX RpY2FsIGNv bXBhbnkgdG hhdCBmb2N1 c2VzIG9uIG RldmVsb3Bp bmcsIG1hbn VmYWN0dXJp bmcsIGFuZC BtYXJrZXRp bmcgaW5ub3 ZhdGl2ZSBh bmQgaGlnaC 1xdWFsaXR5 IG1lZGljaW 5lcyBmb3Ig dGhlIHRyZW F0bWVudCBv ZiB2YXJpb3 VzIGRpc2Vh c2VzIGFuZC Bjb25kaXRp b25zLiBJdH MgYnVzaW5l c3MgbW9kZW wgcmV2b2x2 ZXMgYXJvdW 5kIHRoZSBm b2xsb3dpbm cga2V5IGFz cGVjdHM6PG JyPjEuIFJl c2VhcmNoIG FuZCBEZXZl bG9wbWVudC AoUiZEKTog QXN0ZWxsYX MgUGhhcm1h IGludmVzdH MgaGVhdmls eSBpbiBSJk QgdG8gZGlz Y292ZXIgYW 5kIGRldmVs b3AgbmV3IG RydWdzIGFu ZCB0cmVhdG 1lbnRzLiBU aGUgY29tcG FueSBoYXMg YSBnbG9iYW wgbmV0d29y ayBvZiByZX NlYXJjaCBj ZW50ZXJzIG FuZCBlbXBs b3lzIGEgdG VhbSBvZiBz Y2llbnRpc3 RzIGFuZCBy ZXNlYXJjaG VycyB3aG8g d29yayBjb2 xsYWJvcmF0 aXZlbHkgdG 8gaWRlbnRp ZnkgYW5kIG RldmVsb3Ag cG90ZW50aW FsIGRydWcg Y2FuZGlkYX Rlcy48YnI+ Mi4gU3RyYX RlZ2ljIFBh cnRuZXJzaG lwcyBhbmQg Q29sbGFib3 JhdGlvbnM6 IEFzdGVsbG FzIFBoYXJt YSBjb2xsYW JvcmF0ZXMg d2l0aCBvdG hlciBwaGFy bWFjZXV0aW NhbCBjb21w YW5pZXMsIG FjYWRlbWlj IGluc3RpdH V0aW9ucywg YW5kIHJlc2 VhcmNoIG9y Z2FuaXphdG lvbnMgdG8g YWNjZXNzIG 5ldyB0ZWNo bm9sb2dpZX MsIHNoYXJl IGtub3dsZW RnZSwgYW5k IGFkdmFuY2 UgaXRzIFIm RCBlZmZvcn RzLiBUaGUg Y29tcGFueS BhbHNvIHNl ZWtzIHRvIG FjcXVpcmUg b3IgbGljZW 5zZSBwcm9t aXNpbmcgY2 9tcG91bmRz IGFuZCB0ZW Nobm9sb2dp ZXMgZnJvbS BleHRlcm5h bCBzb3VyY2 VzIHRvIGV4 cGFuZCBpdH MgcHJvZHVj dCBwaXBlbG luZS48YnI+ My4gTWFudW ZhY3R1cmlu ZyBhbmQgU3 VwcGx5IENo YWluOiBBc3 RlbGxhcyBQ aGFybWEgaG FzIGEgZ2xv YmFsIG1hbn VmYWN0dXJp bmcgYW5kIH N1cHBseSBu ZXR3b3JrIH RoYXQgcHJv ZHVjZXMgYW 5kIGRpc3Ry aWJ1dGVzIG l0cyBwcm9k dWN0cyB0by B2YXJpb3Vz IG1hcmtldH Mgd29ybGR3 aWRlLiBUaG UgY29tcGFu eSBlbnN1cm VzIHRoZSBo aWdoZXN0IH N0YW5kYXJk cyBvZiBxdW FsaXR5IGFu ZCBjb21wbG lhbmNlIGlu IGl0cyBtYW 51ZmFjdHVy aW5nIHByb2 Nlc3NlcyB0 byBtZWV0IH JlZ3VsYXRv cnkgcmVxdW lyZW1lbnRz Ljxicj40Li BNYXJrZXRp bmcgYW5kIF NhbGVzOiBB c3RlbGxhcy BQaGFybWEg bWFya2V0cy BpdHMgcHJv ZHVjdHMgdG hyb3VnaCBh IG5ldHdvcm sgb2Ygc2Fs ZXMgcmVwcm VzZW50YXRp dmVzIHRvIG hlYWx0aGNh cmUgcHJvZm Vzc2lvbmFs cyBhbmQgaG 9zcGl0YWxz LiBUaGUgY2 9tcGFueSB1 c2VzIHZhcm lvdXMgbWFy a2V0aW5nIH N0cmF0ZWdp ZXMgdG8gcm Fpc2UgYXdh cmVuZXNzIG FuZCBwcm9t b3RlIGl0cy Bwcm9kdWN0 cywgaW5jbH VkaW5nIHRy YWRpdGlvbm FsIGFkdmVy dGlzaW5nLC BtZWRpY2Fs IGNvbmZlcm VuY2VzLCBh bmQgZWR1Y2 F0aW9uYWwg cHJvZ3JhbX MuPGJyPjUu IEdsb2JhbC BHcm93dGgg YW5kIEV4cG Fuc2lvbjog QXN0ZWxsYX MgUGhhcm1h IGhhcyBhIG ZvY3VzZWQg YXBwcm9hY2 ggdG8gZXhw YW5kIGl0cy BnbG9iYWwg Zm9vdHByaW 50IGJ5IGVu dGVyaW5nIG 5ldyBtYXJr ZXRzLCBwYX J0aWN1bGFy bHkgaW4gZW 1lcmdpbmcg ZWNvbm9taW VzLCBhbmQg ZGl2ZXJzaW Z5aW5nIGl0 cyBwcm9kdW N0IHBvcnRm b2xpby4gVG hlIGNvbXBh bnkgYWxzby BzZWVrcyB0 byBlc3RhYm xpc2ggcGFy dG5lcnNoaX BzIHdpdGgg bG9jYWwgY2 9tcGFuaWVz IHRvIHN0cm VuZ3RoZW4g aXRzIHByZX NlbmNlIGlu IGRpZmZlcm VudCByZWdp b25zLjxicj 42LiBDb3Jw b3JhdGUgU2 9jaWFsIFJl c3BvbnNpYm lsaXR5IChD U1IpOiBBc3 RlbGxhcyBQ aGFybWEgaX MgY29tbWl0 dGVkIHRvIG dpdmluZyBi YWNrIHRvIH NvY2lldHkg YW5kIGZvc3 RlcmluZyBz dXN0YWluYW JsZSBncm93 dGggaW4gdG hlIGNvbW11 bml0aWVzIG l0IHNlcnZl cy4gVGhlIG NvbXBhbnkn cyBDU1IgcH JvZ3JhbXMg Zm9jdXMgb2 4gc3VwcG9y dGluZyBoZW FsdGhjYXJl IGluaXRpYX RpdmVzLCBw cm9tb3Rpbm cgZW52aXJv bm1lbnRhbC BzdXN0YWlu YWJpbGl0eS wgYW5kIGlu dmVzdGluZy BpbiBsb2Nh bCBjb21tdW 5pdGllcy48 YnI+SW4gc3 VtbWFyeSwg QXN0ZWxsYX MgUGhhcm1h J3MgYnVzaW 5lc3MgbW9k ZWwgcmV2b2 x2ZXMgYXJv dW5kIGludm VzdGluZyBp biBSJkQsIH N0cmF0ZWdp YyBwYXJ0bm Vyc2hpcHMg YW5kIGNvbG xhYm9yYXRp b25zLCBhIG dsb2JhbCBt YW51ZmFjdH VyaW5nIGFu ZCBzdXBwbH kgY2hhaW4s IG1hcmtldG luZyBhbmQg c2FsZXMsIG dsb2JhbCBn cm93dGggYW 5kIGV4cGFu c2lvbiwgYW 5kIGNvcnBv cmF0ZSBzb2 NpYWwgcmVz cG9uc2liaW xpdHkuIEJ5 IGZvbGxvd2 luZyB0aGlz IG1vZGVsLC B0aGUgY29t cGFueSBhaW 1zIHRvIG9m ZmVyIGlubm 92YXRpdmUg YW5kIGhpZ2 gtcXVhbGl0 eSBtZWRpY2 luZXMgdG8g aW1wcm92ZS BwYXRpZW50 IG91dGNvbW VzIGFuZCBj cmVhdGUgbG 9uZy10ZXJt IHZhbHVlIG ZvciBpdHMg c3Rha2Vob2 xkZXJzLg==
Interesting facts about the company
Astellas Pharma

πŸ“ˆ Want to read more about Astellas Pharma?

Sign up for free or log in

πŸ“₯ Get our free eBook now: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvS1 dxd2ZzYzh1 dVgyZmh6NX h2TUIud2Vi cCIgYWx0PS JBc3RlbGxh cyBQaGFybW EiIHRpdGxl PSJBc3RlbG xhcyBQaGFy bWEiICBjbG Fzcz0iaW1n LWZsdWlkIi BoZWlnaHQ9 OTAgd2lkdG g9OTAgbG9h ZGluZz0nbG F6eScgc3R5 bGU9J2Jvcm Rlci1yYWRp dXM6IDZweD snPgoKICAg ICAgICAgIC AgICAgICAg ICA8ZGl2IH N0eWxlPSdm bGV4OiAxOy B0ZXh0LWFs aWduOiBjZW 50ZXI7IG1h cmdpbi1sZW Z0OiA1cHg7 Jz4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPHAg c3R5bGU9J2 ZvbnQtc2l6 ZTogMjZweD sgY29sb3I6 ICMzMzM7IG 1hcmdpbi1i b3R0b206ID E1cHg7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIPCf k4ggV2FudC B0byByZWFk IG1vcmUgYW JvdXQgQXN0 ZWxsYXMgUG hhcm1hPwog ICAgICAgIC AgICAgICAg ICAgICAgIC A8L3A+Cgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8YSBocmVm PSdpbmRleC 5waHA/cGFn ZT1zaWdudX AnIHN0eWxl PScKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGJhY2tncm 91bmQtY29s b3I6ICMwMD dCRkY7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBjb2xv cjogI2ZmZj sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIH BhZGRpbmc6 IDEwcHggMj BweDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIGJvcmRl ci1yYWRpdX M6IDVweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHRl eHQtZGVjb3 JhdGlvbjog bm9uZTsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGZvbn Qtd2VpZ2h0 OiBib2xkOw ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgbW FyZ2luLXJp Z2h0OiAxMH B4OwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgdHJhbnNp dGlvbjogYm Fja2dyb3Vu ZC1jb2xvci AwLjNzIGVh c2U7JwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgb25tb3 VzZW92ZXI9 J3RoaXMuc3 R5bGUuYmFj a2dyb3VuZE NvbG9yPSIj MDA1NmIzIi cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG 9ubW91c2Vv dXQ9J3RoaX Muc3R5bGUu YmFja2dyb3 VuZENvbG9y PSIjMDA3Qk ZGIic+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBTaWdu IHVwIGZvci BmcmVlCiAg ICAgICAgIC AgICAgICAg ICAgICAgID wvYT4KCiAg ICAgICAgIC AgICAgICAg ICAgICAgID xzcGFuIHN0 eWxlPSdtYX JnaW46IDAg OHB4OyBjb2 xvcjogIzU1 NTsnPm9yPC 9zcGFuPgoK ICAgICAgIC AgICAgICAg ICAgICAgIC AgPGEgaHJl Zj0naW5kZX gucGhwP3Bh Z2U9bG9naW 4nIHN0eWxl PScKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGNvbG9yOi AjMDA3QkZG OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg dGV4dC1kZW NvcmF0aW9u OiB1bmRlcm xpbmU7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBmb250 LXdlaWdodD ogNTAwOyc+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBs b2cgaW4KIC AgICAgICAg ICAgICAgIC AgICAgICAg PC9hPgoKCi AgICAgICAg ICAgICAgIC AgICAgICAg IDxwIHN0eW xlPSdtYXJn aW4tdG9wOi AxNXB4OyBm b250LXNpem U6IDEzcHg7 IGZvbnQtd2 VpZ2h0OiBi b2xkOyBjb2 xvcjogI2Qz MmYyZjsnPg ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAg8J +SoSBMZWFy biBzbWFydG VyIHN0b2Nr IHBpY2tzIH dpdGggPGk+ IlRoZSBDaG Vja2xpc3Qg VmFsdWUgSW 52ZXN0b3Ig 4oCUIEEgU2 1hcnRlciBX YXkgdG8gUG ljayBTdG9j a3MiPC9pPg ogICAgICAg ICAgICAgIC AgICAgICAg ICA8L3A+Cg ogICAgICAg ICAgICAgIC AgICAgICAg ICA8IS0tCi AgICAgICAg ICAgICAgIC AgICAgICAg IDxkaXYgc3 R5bGU9J21h cmdpbi10b3 A6IDEycHg7 IGZvbnQtc2 l6ZTogMTNw eDsgY29sb3 I6ICM0NDQ7 Jz4KICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IFNpZ24gdX Agbm93IGFu ZCBnZXQgb3 VyIGZyZWUg ZUJvb2sgCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICA8Yj 5UaGUgQ2hl Y2tsaXN0IF ZhbHVlIElu dmVzdG9yIO KAlCBBIFNt YXJ0ZXIgV2 F5IHRvIFBp Y2sgU3RvY2 tzPC9iPgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8L2Rpdj4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgLS0+CiAg ICAgICAgIC AgICAgICAg ICAgICAgID whLS0KICAg ICAgICAgIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nbWFyZ2 luLXRvcDog MTZweDsgZm 9udC1zaXpl OiAxNHB4Oy Bjb2xvcjog IzQ0NDsgZm 9udC1mYW1p bHk6IC1hcH BsZS1zeXN0 ZW0sIEJsaW 5rTWFjU3lz dGVtRm9udC wgU2Vnb2Ug VUksIFJvYm 90bywgSGVs dmV0aWNhIE 5ldWUsIHNh bnMtc2VyaW Y7IGxpbmUt aGVpZ2h0Oi AxLjY7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIEhh dmUgeW91IG hlYXJkIGFi b3V0IG91ci BzaG9ydCA8 c3Ryb25nIH N0eWxlPSdm b250LXdlaW dodDogNjAw Oyc+RGFpbH kgVmlkZW8g TmV3c2xldH Rlcjwvc3Ry b25nPj8KIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIDxhIG hyZWY9J2h0 dHBzOi8vd3 d3Lmluc2ln aHRmdWx2YW x1ZS5jb20v bmV3c2xldH Rlci5waHAn IHRhcmdldD 0nX2JsYW5r JyBzdHlsZT 0nY29sb3I6 ICMwMDdCRk Y7IHRleHQt ZGVjb3JhdG lvbjogbm9u ZTsgZm9udC 13ZWlnaHQ6 IDUwMDsgbW FyZ2luLWxl ZnQ6IDZweD snPgogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIEZp bmQgb3V0IG 1vcmUKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIDwvYT4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPC9kaXY+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgIC0tPgog ICAgICAgIC AgICAgICAg ICAgIDwvZG l2PgogICAg ICAgICAgIC AgICAgPC9k aXY+CiAgIC AgICAgICAg IDwvZGl2Pg ogICAgICAg ICAgICAKIC AgICAgICAK ICAgICAgIC A8c3BhbiBj bGFzcz0nYm x1cnJlZC10 ZXh0Jz4KIC AgICAgICAg ICAgTVM0Z1 FYTjBaVyB4 c1lYTWdVR2 hoIGNtMWhJ SGRoY3kgQm 1iM0p0WldR ZyBhVzRnTW pBd05TIEIw YUhKdmRXZG 8gSUhSb1pT QnRaWCBKbl pYSWdiMlln IGRIZHZJRX BoY0cgRnVa WE5sSUhCby BZWEp0WVdO bGRYIFJwWT JGc0lHTnYg YlhCaGJtbG xjeSB3Z1dX RnRZVzV2IG RXTm9hU0JR YUcgRnliV0 ZqWlhWMCBh V05oYkNCRG J5IDRnWVc1 a0lFWjEgYW 1sellYZGhJ RiBCb1lYSn RZV05sIGRY UnBZMkZzSU UgTnZManhp Y2o0eSBMaU JVYUdVZ1ky IDl0Y0dGdW VlS0EgbVhN Z1oyeHZZbS BGc0lHaGxZ V1J4IGRXRn lkR1Z5Y3kg QnBjeUJzYj JOaCBkR1Zr SUdsdUlGIF J2YTNsdkxD QksgWVhCaG Jpd2dZbiBW MElHbDBJR0 ZzIGMyOGdh R0Z6SUcgRW djMmxuYm1s bSBhV05oYm 5RZ2NIIEps YzJWdVkyVW cgYVc0Z2Iz Um9aWCBJZ1 kyOTFiblJ5 IGFXVnpJSE 4xWTIgZ2dZ WE1nZEdobC BJRlZ1YVhS bFpDIEJUZE dGMFpYTXMg SUVWMWNtOX daUyB3Z1lX NWtJRUZ6IG FXRXVQR0p5 UGogTXVJRU Z6ZEdWcyBi R0Z6SUhOd1 pXIE5wWVd4 cGVtVnogSU dsdUlHUmxk bSBWc2IzQn BibWNnIFlX NWtJRzFoYm 4gVm1ZV04w ZFhKcCBibW NnYldWa2FX IE5wYm1Wek lHbHUgSUhO bGRtVnlZVy B3Z2RHaGxj bUZ3IFpYVj BhV01nWVgg SmxZWE1zSU dsdSBZMngx WkdsdVp5IE IxY205c2Iy ZDUgTENCdm JtTnZiRyA5 bmVTd2dhVz F0IGRXNXZi RzluZVMgd2 dZVzVrSUds dSBabVZqZE dsdmRYIE1n WkdselpXRn ogWlhNdVBH SnlQaiBRdU lGUm9aU0J1 IFlXMWxJRU Z6ZEcgVnNi R0Z6SUdsei BJR1JsY21s MlpXIFFnWm 5KdmJTQjAg YUdVZ1IzSm xaVyBzZ2Qy OXlaSE1nIF lYTjBaWElz SUcgMWxZVz VwYm1jZyBj M1JoY2l3Z1 lXIDVrSUd4 dloyOXogTE NCdFpXRnVh VyA1bklIZH ZjbVFnIGIz SWdiV1Z6Yz IgRm5aU3dn Y21WdyBjbV Z6Wlc1MGFX IDVuSUhSb1 pTQmogYjIx d1lXNTU0by BDWmN5Qmpi MjF0IGFYUn RaVzUwSUgg UnZJSE5vYV c1cCBibWNn WVNCc2FXIG RvZENCdmJp QnUgWlhjZ2 FXUmxZWCBN Z1lXNWtJR0 p5IGFXNW5h VzVuSUggUm 9aVzBnZEc4 ZyBiR2xtWl M0OFluIEkr TlM0Z1NXNG cgWVdSa2FY UnBiMiA0Z2 RHOGdjR2ho IGNtMWhZMl YxZEcgbGpZ V3h6TENCQi BjM1JsYkd4 aGN5IEJoYk hOdklHaGgg Y3lCaElITj BjbSA5dVp5 Qm1iMk4xIG N5QnZiaUJ5 WlcgZGxibV Z5WVhScCBk bVVnYldWa2 FXIE5wYm1V Z1lXNWsgSU dseklHRmpk RyBsMlpXeD VJR2x1IGRt VnpkR2x1Wn kgQnBiaUJ6 ZEdWdCBJR0 5sYkd3Z2Nt IFZ6WldGeV kyZ2cgWVc1 a0lIUmxZMi BodWIyeHZa M2t1IFBHSn lQall1SUUg RnpkR1ZzYk dGeiBJR2ho Y3lCaVpXIF Z1SUhKbFky OW4gYm1sNl pXUWdabSA5 eUlHbDBjeU J6IGRYTjBZ V2x1WVcgSn BiR2wwZVNC bCBabVp2Y2 5SekxDIEJw Ym1Oc2RXUn AgYm1jZ1lt VnBibSBjZ2 JtRnRaV1Fn IGIyNWxJRz ltSUggUm9a U0JYYjNKcy BaT0tBbVhN Z1RXIDl6ZE NCRmRHaHAg WTJGc0lFTn ZiWCBCaGJt bGxjeUJpIG VTQjBhR1Vn UlggUm9hWE 53YUdWeSBa U0JKYm5OMG FYIFIxZEdV Z1ptOXkgSU hObGRtVnlZ VyB3Z1kyOX VjMlZqIGRY UnBkbVVnZV cgVmhjbk11 UEdKeSBQam N1SUZSb1pT IEJqYjIxd1 lXNTUgSUds eklHTnZiVy AxcGRIUmxa Q0IwIGJ5Qm 5hWFpwYm0g Y2dZbUZqYX lCMCBieUIw YUdVZ1kyID l0YlhWdWFY UnAgWlhNZ2 FYUWdjMiBW eWRtVnpJSF JvIGNtOTFa MmdnZG0gRn lhVzkxY3lC aiBiM0p3Yj NKaGRHIFVn YzI5amFXRn MgSUhKbGMz QnZibiBOcF ltbHNhWFI1 IElIQnliMm R5WVcgMXpM Q0JwYm1Ocy BkV1JwYm1j Z2MzIFZ3Y0 c5eWRHbHUg WnlCb1pXRn NkRyBoallY SmxJR0ZqIF kyVnpjeUJo Ym0gUWdaV1 IxWTJGMCBh Vzl1SUdsdW FYIFJwWVhS cGRtVnogTG p4aWNqNDRM aSBCSmJpQX lNREE0IExD QkJjM1JsYk cgeGhjeUJp WldOaCBiV1 VnZEdobElH IFpwY25OME lIQm8gWVhK dFlXTmxkWC BScFkyRnNJ R052IGJYQm hibmtnZEcg OGdjR0Z5ZE c1bCBjaUIz YVhSb0lIIF JvWlNCSmJu UmwgY201aG RHbHZibSBG c0lGTndZV0 5sIElGTjBZ WFJwYjIgNG dLRWxUVXlr ZyBUbUYwYV c5dVlXIHdn VEdGaWIzSm ggZEc5eWVT d2dZMiA5dV pIVmpkR2x1 IFp5QnlaWE 5sWVggSmph Q0J2YmlCaC BiblJwTFdO aGJtIE5sY2 lCa2NuVm4g Y3lCcGJpQn RhVyBOeWIy ZHlZWFpwIG RIa3VQR0p5 UGoga3VJRU Z6ZEdWcyBi R0Z6SUdoaG N5IEJoSUhO MGNtOXUgWn lCd2FYQmxi RyBsdVpTQn ZaaUJ1IFpY Y2dZVzVrSU cgbHVibTky WVhScCBkbV VnZEhKbFlY IFJ0Wlc1MG N5d2cgZDJs MGFDQnZkbS BWeUlEY3dJ R05zIGFXNX BZMkZzSUgg UnlhV0ZzY3 lCaiBkWEp5 Wlc1MGJIIG tnZFc1a1pY SjMgWVhrZ2 QyOXliRyBS M2FXUmxMan hpIGNqNHhN QzRnVkcgaG xJR052YlhC aCBibmtnYU dGeklIIEps WTJWcGRtVm sgSUc1MWJX VnliMyBWek lHRjNZWEpr IGN5QmhibV FnY20gVmpi MmR1YVhScC BiMjV6SUda dmNpIEJwZE hNZ2NISnYg WkhWamRITX NJSCBKbGMy VmhjbU5vIE xDQmhibVFn WW4gVnphVz VsYzNNZyBi M0JsY21GMG FXIDl1Y3l3 Z2FXNWogYk hWa2FXNW5J RyBKbGFXNW 5JRzVoIGJX VmtJRzl1Wl MgQnZaaUIw YUdVZyBWRz l3SURVd0lF IE52YlhCaG JtbGwgY3lC bWIzSWdSRy BsMlpYSnph WFI1IElHSj VJRVJwZG0g VnljMmwwZV VsdSBZeTQ9 CiAgICAgIC AgPC9zcGFu PgogICAgIC AgIAogICAg ICAgIA==
See Company Q&A
Astellas Pharma

πŸ“Š Get full analytics about Astellas Pharma

Sign up for free or log in

πŸ“š Your free copy of "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" is waiting

© 2024 - 2026 InsightfulValue.com. All rights reserved. Newsletter
Legal